Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar verncox (< 20) Submitted: 2/14/2007 11:46:06 PM : Outperform Start Price: $12.16 ASTM Score: -79.39

Flucuates between .50 and 5.00

Featured Broker Partners


Advertisement